HEIDI RUSSELL to 3-Iodobenzylguanidine
This is a "connection" page, showing publications HEIDI RUSSELL has written about 3-Iodobenzylguanidine.
Connection Strength
0.231
-
A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study. Pediatr Blood Cancer. 2021 10; 68(10):e29117.
Score: 0.200
-
Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):858-62.
Score: 0.031